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a-Synuclein (AS) plays a crucial role in Parkinson’s disease pathogenesis. AS is normally secreted from
neuronal cells and can thus exert paracrine effects. We have previously demonstrated that naturally
secreted AS species, derived from SH-SY5Y cells inducibly overexpressing human wild type AS, can be
toxic to recipient neuronal cells. In the current study, we show that application of secreted AS alters
membrane ﬂuidity and increases calcium (Ca2þ) entry. This inﬂux is reduced on pharmacological inhi-
bition of voltage-operated Ca2þ channels. Although no change in free cytosolic Ca2þ levels is observed, a
signiﬁcantly increased mitochondrial Ca2þ sequestration is found in recipient cells. Application of
voltage-operated Ca2þ channel blockers or Ca2þ chelators abolishes AS-mediated toxicity. AS-treated
cells exhibit increased calpain activation, and calpain inhibition greatly alleviates the observed
toxicity. Collectively, our data suggest that secreted AS exerts toxicity through engagement, at least in
part, of the Ca2þ homeostatic machinery. Therefore, manipulating Ca2þ signaling pathways might
represent a potential therapeutic strategy for Parkinson’s disease.
 2013 Elsevier Inc. All rights reserved.1. Introduction
The pathological hallmark of Parkinson’s disease (PD) is the loss
of the dopaminergic neurons primarily in the substantia nigra pars
compacta and the presence of proteinaceous inclusions, termed
Lewy bodies and Lewy neutites, in the somata or axons, respec-
tively, of the remaining neurons (Dauer and Przedborski, 2003;
Spillantini et al., 1997). The primary structural component of
these intraneuronal aggregates is a-synuclein (AS), a small acidic
protein that is mainly found in presynaptic terminals. AS is genet-
ically linked to familial and sporadic disease (Gasser, 2009; Nalls
et al., 2011). Importantly, AS is detected in human biological
ﬂuids and in the culture medium of neuronal cells, suggesting a
possible paracrine mode of action in the extracellular milieu
(Vekrellis et al., 2011). AS has been found to be secreted, via a
nonclassical, calcium-dependent mechanism that partly relies on
exosomes (Emmanouilidou et al., 2010), small extracellular vesiclesciences, Biomedical Research
anou Efessiou Street, Athens
597545.
llis).
ll rights reserved.which derive from endosomes after fusing with the plasma mem-
brane (Chivet et al., 2012). Extracellular AS can be toxic to recipient
cells, and has assumed an augmented importance, for the reason
that it might be involved in disease propagation, otherwise known
as ‘spreading’ in the context of PD (Kordower et al., 2008; Li et al.,
2008).
It has been shown that aberrant forms of recombinant AS
(oligomers, aggregates) can create pores that compromise plasma
membrane integrity, much like other aggregating-prone proteins
such as amyloid beta peptide and prion (Danzer et al., 2007; Tsigelny
et al., 2012). Alternatively, such proteins can interact with calcium
(Ca2þ) channels, thereby altering their function and compromising
Ca2þ equilibrium between intracellular and extracellular spaces
(Demuro et al., 2010). Ca2þ ions play a pivotal role in neuronal
plasticity and survival (Berridge et al., 2003; Greer and Greenberg,
2008); thus, an extremely complex homeostatic network operates
to regulate intracellular Ca2þ levels. Ca2þ inﬂux has long been
considered as a key source of Ca2þ signals, and together with Ca2þ
release from internal stores, such as the endoplasmic reticulum
(ER), plays a major role in Ca2þ homeostasis (Patel and Docampo,
2010). Acidic organelles have also been shown to be intracellular
Ca2þ stores (Churchill et al., 2002; Yamasaki et al., 2004) and
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and cell physiology (Patel and Docampo, 2010). Additionally, mito-
chondria play a very important role on Ca2þ signaling, being phys-
ically and functionally linked to the ER, thus shaping intracellular
Ca2þ responses (de Brito and Scorrano, 2008; Lamarca and Scorrano,
2009).
Deregulation of Ca2þ homeostasis has been recently proposed as
a major age-related condition driving neurodegeneration in spo-
radic PD (Zundorf and Reiser, 2011). This view is supported by the
ﬁnding that dopaminergic neurons expressing higher levels of
Ca2þ-binding proteins, such as calbindin D28K, calretinin, and
parvalbumin, seem to be resistant to degeneration in PD (Surmeier
et al., 2010). Moreover, recombinant AS has been shown to trigger
Ca2þ inﬂux and induce caspase activation in a variety of neuronal
systems (Danzer et al., 2007; Furukawa et al., 2006; Martin et al.,
2012). However, the effects of cell-derived naturally secreted AS
on Ca2þ homeostasis in a neuronal cell context have not been
assessed.
To address this issue, we have used the human SH-SY5Y neuro-
blastoma cell line, in which the expression of humanwild type (WT)
AS can be induced, as a source of naturally secreted AS (Vekrellis
et al., 2009). We have previously shown that these cells readily
secrete a wide range of AS species, which are toxic to recipient
neuronal cells (Emmanouilidou et al., 2010). Here, we show that
application of medium enriched in secreted AS on neuronally
differentiated SH-SY5Y cells and primary rat cortical neurons, is
accompanied by perturbation of Ca2þ homeostasis and neuronal
death. These effects are ameliorated by blockage of voltage-operated
Ca2þ channels (VOCs), Ca2þ chelation, or calpain inhibition. The in-
crease in Ca2þ inﬂux is mostly attributed to free extracellular, rather
than exosome-associated AS. We further show that extracellular AS
alters membrane ﬂuidity properties of the recipient cells, and evokes
Ca2þ sequestration into the mitochondria. Collectively, our data
suggest that secreted AS is toxic to recipient neuronal cells, at least in
part, through the disruption of the Ca2þ homeostatic machinery.
2. Methods
2.1. Reagents
Reagents were obtained from Sigma-Aldrich (St Louis, MO, USA)
unless otherwise speciﬁed. G agarose beads, Fluorogenic Substrate
IV, and Fura 2-AM calcium indicator were purchased from Calbio-
chem (San Diego, CA, USA). Carbonyl cyanide p-triﬂuromethoxy-
phenylhydrazone (FCCP), u-conotoxin GVIA (cntx) and SKF 96365
hydrochloride (SKF) were purchased from Tocris Bioscience.
1-Pyrenedodecanoic acid was obtained from Molecular Probes/
Invitrogen (Eugene, OR, USA).
2.2. Cell culture
Stable SH-SY5Y cell lines inducibly expressing WT AS were
generated as previously described (Vekrellis et al., 2009). Cells
were cultured in RPMI 1640 medium containing 10% fetal bovine
serum (FBS), penicillin (100 U/mL), streptomycin (100 mg/mL), and
2mM L-glutamine. AS expressionwas switched off by the addition
of doxycycline (dox) (1.0 mg/mL). Neuronal differentiation was
performed with the addition of 10 mM all-trans retinoic acid for
6 days. Cultures of rat (embryonic day 18) cortical neurons were
prepared as previously described (Vogiatzi et al., 2008). Dissoci-
ated cells were plated onto polyeD-lysine-coated 24-well dishes
at a density of 150,000e200,000 cells per cm2 and maintained in
Neurobasal medium (Gibco, Invitrogen), containing 2% B27 sup-
plement (Gibco, Invitrogen), 0.5 mM L-glutamine, and 1% peni-
cillin/streptomycin.2.3. Preparation of conditioned medium
SH-SY5Y cells inducibly expressing WT AS were cultured in 140
mmdishes in RPMImedium containing 10% FBS in the presence (1.0
mg/mL) or absence of dox until 70%e80% conﬂuency was reached.
The mediumwas then replaced with RPMI containing 2% FBS. After
48 hours, the culture supernatant (conditioned medium [CM]) was
collected and centrifuged sequentially at 400g for 5 minutes at 4 C
to remove unbroken cells and at 4000g for 10 minutes at 4 C to
remove cell debris.
2.4. Exosome puriﬁcation
Before use, FBS exosomes were depleted from the culture
medium as described previously (Thery et al., 2006). Before exo-
some isolation, the culture medium of SH-SY5Y cells was replaced
with exosome-depleted medium diluted 10-fold with RPMI con-
taining only penicillin/streptomycin and L-glutamine for 48 hours.
The culture supernatant was collected and sequentially centri-
fuged at 400g for 10 minutes, and at 2000g for 10 minutes, 10,000g
for 30 minutes, and 100,000g for 90 minutes. The obtained pellet
(P100) containing mostly exosomes was washed once with ice-
cold phosphate buffered saline (PBS) and centrifuged again at
100,000g for 90 minutes. The ﬁnal P100 pellet was resuspended in
PBS buffer or lysed in radioimmunoprecipitation assay (RIPA)
buffer.
2.5. Immunodepletion of AS from CM
AS was immunodepleted from CM as described previously
(Emmanouilidou et al., 2010). The anti-AS antibody (Syn-1, mouse
monoclonal; BD Biosciences; 0.5 mg antibody per mL CM) was used
to immunoprecipitate AS from the CM overnight. Immunodepleted
CM was collected and sterilized through a 0.2 mm ﬁlter (Whatman)
before application to recipient cells. Control immunodepletion was
performed using an antiec-myc antibody of the same isotype
(mouse monoclonal; Santa Cruz Biotechnology).
2.6. Western blot analysis
For Western blot analysis, CM and exosome-depleted superna-
tants (S100) were concentrated using 3-kDa cutoff Amicon Ultra
ﬁlters (Millipore). The P100 containing exosomes was reconstituted
in 25 mL of RIPA buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1%
NP-40, 0.5% Na deoxycholate, and 0.1% sodium dodecyl sulfate).
Denaturing gel electrophoresis was performed in 12% sodium
dodecyl sulfate polyacrylamide gel electrophoresis gels in Tris-
glycine buffer. Immunoblot analysis was performed using the
following antibodies: anti-AS (rabbit polyclonal; C-20), anti-bovine
serum albumin (anti-BSA) (mouse monoclonal), anti-Alix (mouse
monoclonal), and anti-Flotillin (mouse monoclonal). All antibodies
were from Santa Cruz Biotechnology.
2.7. Assessment of survival
Six-day differentiated SH-SY5Y neuroblastoma cells or 7-day-
old rat cortical neurons were treated with AS-containing (CM,
WT) or control (CM, WTþ) CM in the presence or absence of Ca2þ
modulators or calpain inhibitors. Concentrations of the compounds
are mentioned in the ﬁgures. Recipient cells were lysed in a
detergent-containing solution, which enables the quantiﬁcation of
viable cells by counting the number of intact nuclei in a hema-
tocytometer (Farinelli et al., 1998; Stefanis et al., 1999). Cell counts
were performed in triplicate.
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Six-day differentiated SH-SY5Y human neuroblastoma cells,
grown in 6-well plates, were incubated with control CM or CM
containing secreted AS for 8, 12, 16, and 24 hours. Recipient cells
were washed with ice-cold PBS and homogenized in a buffer con-
taining 10 mM HEPES (pH 7.5), 5 mM DTT, 1% NP-40 on ice for 30
minutes. Cell lysates (2 mg) were mixed with 25 mL of activity buffer
(50 mM Tris-HCl [pH 7.6], 150 mM NaCl, 5 mM DTT, 10 mM CaCl2)
containing 10 mM ﬂuorogenic calpain substrate (Calpain Substrate
IV; Calbiochem, San Diego, CA, USA) and incubated at room tem-
perature for 40 minutes in the dark. The reaction was stopped by
adding 500 mL of 50 mM EDTA. Calpain activity was measured at
320 nm after excitation at 480 nm in a Perkin-Elmer LS-55 lumi-
nescence spectometer (Perkin-Elmer, Norwalk, CT, USA). To test the
speciﬁcity of the assay, 200 mM of the calpain inhibitor I A6185 (CI)
was included where indicated (Banoczi et al., 2008).
2.9. 1-Pyrenedodecanoic acid ﬂuorescence measurements
1-Pyrenedodecanoic acid labeling of plasma membranes and
ﬂuorescence measurements were carried out as described else-
where (Galla and Luisetti, 1980; Hashimoto et al., 1999). SH-SY5Y
cells were seeded on 6-well plates at a density of 1.0  105 cells
per well, and differentiated for 6 days. Subsequently, cells were
treated with secreted CM, WT for 8 hours at 37 C. At the end of
the incubation period, cells were resuspended in PBS and trans-
ferred into a ﬂuorimeter cuvette. 1-Pyrenedodecanoic acid (2 mM)
was added for 5 minutes in the dark at room temperature (RT).
After excitation at 340 nm, the ﬂuorescence intensity was scanned
from 380 to 580 nm in a luminescence spectrometer. The ratio of
the maximum ﬂuorescent intensity of excimer and pyrene mono-
mers was calculated at 468 and 395 nm, respectively.
2.10. Free cytosolic Ca2þ measurements
Cells were loaded with Fura 2-AM as described (Papazaﬁri et al.,
1994). Brieﬂy, 6-day differentiated SH-SY5Y cells were treated with
control or secreted CM,WT for 8 hours, harvested in RPMI culture
medium and centrifuged at 400g for 5 minutes at RT. Cell pellets
were suspended in Krebs-Ringer-HEPES (KRH) buffer (125 mM
NaCl, 5 mM KCl, 1.2 mM KH2PO4, 1.2 mMMgSO4, 2 mM CaCl2, 6 mM
D-glucose, and 25 mM HEPES-NaOH [pH 7.4]) containing 2% FBS,
counted in a hemocytometer and loaded with Fura 2-AM dye (2.5
mM), for 30 minutes at RT in the dark. Cells were resuspendend in
KRH supplemented with 250 mM sulﬁnpyrazone to prevent dye
leakage, transferred to a thermostatted cuvette (37 C), maintained
in a continuous stirring condition, and analyzed in a Perkin-Elmer
LS-55 luminescence spectrometer. To estimate capacitative cal-
cium entry (CCE), 1.8  106 cells were resuspended in a CaCl2-
deprived KRH medium and 10 mM EGTA was added. Thapsigargin
([Tg] 100 nM) was added to deplete ER Ca2þ stores; CaCl2 (3 mM)
was reintroduced into the medium and the ensuing CCE was
recorded. Results represent the maximal peak values normalized to
ER content as exempliﬁed by Tg-induced Ca2þ efﬂux of at least 3
independent experiments. Nifedipine ([nif] 1 mM), cntx (100 nM), or
SKF (10 mM) was added after EGTA normalization and before the
addition of Tg. VOCs were stimulated with 55 mM KCl, in the
presence or absence of either 1 mM nif or 100 nM cntx. To estimate
Ca2þ load in the diverse subcellular compartments, intracellular
Ca2þ pools were depleted sequentially with the addition of the
appropriate pharmacological compounds: 5 mM carbachole (Cch),
followed by the addition of 100 nM Tg, 500 nM ionomycin (Iono),
and 20 mMmonensin A, in the presence or absence of extracellular
Ca2þ. To estimate the mitochondrial Ca2þ load, 1.8  106 Fura2-loaded cells suspended in Ca2þ-deprived KRH, were treated with
5 mMof the mitochondrial uncoupler FCCP, together with 2.5 mg/mL
oligomycin (Oligo), to prevent ATP consumption via the reversed
mode activity of the F1/F0 synthase.
2.11. Live Ca2þ imaging
For live Ca2þ imaging, 7-day-old rat cortical neurons (75,000 cells
per chamber) plated on poly-L-lysine-coated 8-chamber slides (In-
tegrated BioDiagnostics, Munich, Germany), were incubated with 2
mM Fura 2-AM in culture medium for 30 minutes at 37 C, then
returned to culture medium and incubated for 3 hours at 37 C. Just
beforeCa2þmeasurements, cellswerewashedoncewithmicroscopy
buffer (129mMNaCl, 5mMKCl,1mMMgCl2, 30mMglucose,1%BSA,
25 mMHEPES [pH 7.4]) and positioned in a temperature-controlled
microscope. During measurements, CCE was assessed using stimu-
lation with 0.25 mM Tg, followed by the addition of 6 mM CaCl2.
Fluorescence images obtained at 340 and 380 nm excitation and 510
nm emission were acquired by using a TE 2000U-inverted ﬂuores-
cence microscope (Nikon, Osaka, Japan) coupled to a cooled charge-
coupled device (CCD) camera (PTI-IC200) (Princeton Instruments).
At the endof each experiment, the Fura2-AMsignalswere calibrated
with the simultaneous addition of 10 mM Iono and 50 mM KCl, to
obtain the maximum ﬂuorescence. Images were acquired every 10
seconds and cells were analyzed using the region of interest tool, to
extract the ﬂuorescence ratios. Changes in Ca2þ were determined
using temporal analyses of single cells to express the data as ﬂuo-
rescence ratios as described (Smaili and Russell, 1999). The baseline
ﬂuorescencewasdeterminedat thebeginningof eachexperimentby
obtaining the average of the ﬁrst 20 data points before compound
addition, using the Image Master 3 Software (Graph-Pad Prism 4.0)
acquisition-analysis software (PTI, Birmingham, NJ, USA). The re-
sults were normalized in relation to the baseline ﬂuorescence and
the data expressed as a percent of increase relative to baseline. The
histograms represent the average peak response.
2.12. Statistical analysis
All data are expressed as mean  standard error of the mean
(SEM). Statistical analysis for multiple comparisons was performed
using a 1-way analysis of variance followed by Tukey honestly sig-
niﬁcant difference (HSD) post hoc test. Nondirectional Student t
tests were performed for comparisons involving only 2 groups. All
statistical analyses were conducted using the Graph-Pad Prism
software. Resultswere considered statistically signiﬁcant at p0.05.
3. Results
3.1. Secreted AS induces an increase in capacitative Ca2þ entry in
neuronally differentiated SH-SY5Y neuroblastoma cells
We wanted to investigate whether the mechanism via which
secreted AS triggers the neurotoxic cascade involves alterations in
the Ca2þ homeostastic machinery. As a source of cell-secreted AS,
we used CM from SH-SY5Y cells inducibly overexpressing human
WT AS (Emmanouilidou et al., 2010; Vekrellis et al., 2009). To
elucidate the events that precede AS-induced cell death, we
applied CM from the induced (CM, WT) or the control uninduced
cells (CM, WTþ) to differentiated SH-SY5Y cells for 8 hours,
because this was the longest incubation time during which the
recipient cells did not exhibit any morphological or biochemical
characteristics of cell degeneration (data not shown). After the 8-
hour treatment, free cytosolic Ca2þ ([Ca2þ]i) recordings of the
recipient cells were obtained using the Fura 2-AM dye. After ER
depletion by Tg (100 nM), we measured CCE using exogenous
Fig. 1. Application of secreted AS increases CCE in differentiated, but not in proliferating recipient SH-SY5Y cells. (A) Differentiated SH-SY5Y cells were treated with CM, WT or CM,
WTþ for 8 hours and CCE was measured as described. Representative Ca2þ measurements depicting CCE are shown in the left panel and quantitative analysis of the percentage of
Ca2þ inﬂux, normalized to Tg-evoked Ca2þ release (ﬁrst peak), is depicted in the right panel (n ¼ 16; *** p < 0.001). (B) Differentiated SH-SY5Y cells were treated with AS-depleted
(CM, WT/Syn-1 IP) or control immunodepleted (CM, WT/c-myc IP) CM for 8 hours. Representative Ca2þmeasurements are shown in the left panel and quantitative analysis of the
percentage of Ca2þ inﬂux is depicted in the right panel (n ¼ 3; * p < 0.05, comparing cells treated with CM, WTþ and CM, WT; # p < 0.05, comparing between cells treated with
CM, WT/Syn-1 IP and cells treated with CM, WT or CM, WT/c-myc IP). (C) Proliferating SH-SY5Y cells were treated with CM, WT or CM, WTþ for 8 hours. The difference in
percentage of Ca2þ inﬂux between cells treated with CM, WTþ and CM, WTwas not statistically signiﬁcant (n ¼ 3). Abbreviations: AS, a-synuclein; Ca2þ, calcium; CCE, capacitative
calcium entry; CM, conditioned medium; CM, WTþ, control CM; CM, WT, AS-containing medium; c-myc IP, control immunoprecipitation; F/F, ﬂuorescence ratio; Syn-1 IP, alpha-
synuclein immunoprecipitation; Tg, thapsigargin.
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SY5Y cells with the secreted CM, WT resulted in a statistically
signiﬁcant increase in [Ca2þ]i, compared with cultures incubated
with CM, WTþ (Fig. 1A). Importantly, this increase in CCE was AS-
dependent, because effective immunodepletion of AS from the
CM, before its application to recipient cells, greatly reduced the Tg-
evoked Ca2þ entry (Fig. 1B). Control immunodepletion with an
irrelevant antibody (c-myc) failed to reduce CCE. In contrast, in-
cubation of proliferating SH-SY5Y cells with the CM, WTþ or the
CM, WT resulted in similar CCE responses (Fig. 1C), suggesting
that secreted AS only disturbs Ca2þ homeostasis in cells that have
a neuronal phenotype.
3.2. Secreted AS-induced increase in Ca2þ entry is ampliﬁed by the
L- and the N-type voltage-operated Ca2þ channels
In neurons, as in many other cell types, Ca2þ ions can enter cells
via a number of channels, such as storage-operated channels
(SOCs), VOCs, and receptor-operated plasma membrane Ca2þ
channels. To assess the contribution of such channels to the AS-
facilitated Ca2þ entry, we ﬁrst examined the participation of SOCs
by blocking them with the SOC-speciﬁc inhibitor, SKF (10 mM).
Addition of SKF resulted in a signiﬁcant reduction in CCE, insecreted AS- and control CM-treated cultures (Fig. 2A and B).
However, the difference in CCE between the 2 groups in the pres-
ence of SKF, was maintained (Fig. 2B), implying that other plasma
membrane channelsmight participate in the observed Ca2þ entry in
the presence of secreted AS.
Previous reports have suggested that AS modulates the function
of VOCs (Adamczyk and Strosznajder, 2006; Hettiarachchi et al.,
2009; Kang et al., 2012). To test such a hypothesis in our cellular
system, we used the L- and N-type speciﬁc VOC blockers, nif (1 mM)
and cntx (100 nM), respectively. We found that nif and cntx reduced
the Tg-evoked Ca2þ entry, only in cells treated with secreted AS
(Fig. 2C and D). These results imply a participation of both L- and N-
type Ca2þ channels in the observed CCE increase. Neither inhibitor
affected the CCE of cells treated with the CM, WTþ. Based on these
ﬁndings we could surmise that in the presence of extracellular AS,
VOCs might become active, thereby contributing to the SOC-
facilitated Ca2þ entry.
To directly investigate the role of VOCs, we stimulated the
cells with 55 mM KCl. Control and AS-treated cells responded
to KCl stimulation robustly, yet Ca2þ entry was signiﬁcantly
greater in the latter (Fig. 2E and F). Addition of either nif or
cntx, signiﬁcantly reduced KCl-induced Ca2þ entry in both
groups, verifying the functionality of these channels. Notably, the
Fig. 2. L-type and N-type VOCs are implicated in the observed secreted AS-induced Ca2þ entry. Differentiated SH-SY5Y cells were treated with CM from AS-expressing (CM, WT) or
control (CM, WTþ) cells for 8 hours. (A and C) Representative Ca2þ measurements depicting CCE in the absence or presence of SKF (A) and nif or cntx (C). (B and D) Quantitative
analysis of the percentage of Ca2þ inﬂux normalized to Tg-evoked Ca2þ release (ﬁrst peak) between groups in the presence/absence of SKF (B) (n ¼ 4, in duplicate; ** p < 0.01,
comparing cells treated with CM, WTþ and CM, WT in the presence/absence of SKF; ## p < 0.01 comparing SKF-treated and SKF-untreated cells) and nif or cntx (D) (n ¼ 5, in
duplicate; * p < 0.05, comparing cells treated with CM, WTþ and CM, WT; ## p < 0.01 comparing cells treated with CM, WT in the presence or absence of nif or cntx). (E)
Representative Ca2þ recordings on KCl stimulation in the presence or absence of nif or cntx. (F) Quantiﬁcation of Ca2þ inﬂux (DnM) after KCl addition, in the presence or absence of
the inhibitors (n ¼ 4, in duplicate; *** p < 0.001, comparing cells treated with CM, WTþ and CM, WT; # p < 0.05 comparing cells treated with CM, WTþ in the presence or absence
of nif or cntx; þþþ p < 0.001, comparing cells treated with CM, WT in the presence or absence of the inhibitors). Abbreviations: AS, a-synuclein; Ca2þ, calcium; CCE, capacitative
calcium entry; CM, conditioned medium; CM, WTþ, control CM; CM, WT, AS-containing medium; cntx, u-conotoxin GVIA; F/F, ﬂuorescence ratio; nif, nifedipine; SKF, SKF 96365
hydrochloride; Tg, thapsigargin; VOC, voltage-operated Ca2þ channel.
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was abolished in the presence of VOC inhibitors (Fig. 2F), high-
lighting the important role of these channels in secreted AS-
facilitated Ca2þ entry.3.3. Naturally secreted AS induces mitochondrial Ca2þ uptake
Increased intracellular AS, and preﬁbrilar forms of recombinant
AS, have been shown to induce higher plasma membrane ion
Fig. 3. AS-facilitated Ca2þ entry is driven to the mitochondria. Differentiated SH-SY5Y cells were treated with secreted CM, WT or CM, WTþ for 8 hours, after labeling with Fura 2-
AM. (A) The concentration of free cytosolic Ca2þ was estimated in Ca2þ-deprived conditions (left panel) and Ca2þ-containing conditions (right panel). No signiﬁcant difference
between the cells treated with CM, WTþ or with the CM, WT was observed in either condition (n ¼ 3, for Ca2þ-deprived conditions; n ¼ 11, for Ca2þ-containing conditions). (B)
Representative Ca2þ recordings depicting changes in [Ca2þ]i on sequential application of Cch, Tg, Iono, and Mon in Ca2þ-deprived conditions (left panel). Quantitative analysis of Ca2þ
mobilization on addition of the compounds in the cells treated with CM, WTþ and CM, WT in Ca2þ-deprived (right panel, n ¼ 3), no statistical signiﬁcant difference in Ca2þ
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Fig. 4. Treatment with naturally secreted AS increases Ca2þ entry in primary rat cortical neurons. Seven-day-old rat cortical neurons were treated with secreted CM, WT or CM,
WTþ for 8 hours. After loading with Fura 2-AM dye, CCE was monitored using a ﬂuorescence microscope. Representative images illustrating the 350/380 ﬂuorescence ratio before
and after Ca2þ administration are shown in the left panel and quantitative analysis of the percentage of ﬂuorescence ratio, normalized to baseline ﬂuorescence, is depicted in the
right panel (n ¼ 3; ** p < 0.005). Abbreviations: AS, a-synuclein; Ca2þ, calcium; CCE, capacitative calcium entry; CM, conditioned medium; CM, WTþ, control CM; CM, WT,
AS-containing medium; % Rmax, percent of increase relative to baseline.
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Furukawa et al., 2006). Taking these, and our results, into account,
we investigated whether the increased Ca2þ entry could lead to a
subsequent rise in [Ca2þ]i levels. To this end, differentiated SH-SY5Y
cells were treated as previously described and [Ca2þ]i levels were
examined in Ca2þ-free and Ca2þ-containing environments. No sig-
niﬁcant difference in [Ca2þ]i was observed between AS-treated and
control-treated cells in either condition (Fig. 3A).
Next, we asked whether the increased Ca2þ entry could lead to
sequestration into speciﬁc intracellular Ca2þ pools. Under Ca2þ-
deprived conditions,weﬁrst added Cch (5 mM), a cholinergic agonist
that activates inositol trisphosphate receptor (IP3R), resulting in
Ca2þ efﬂux from the ER to the cytosol. When the Cch response was
buffered, Tg (100 nM), a noncompetitive inhibitor of sarcoendo-
plasmic reticulum (SR) calcium transport ATPase (SERCA) pumps,
was added to allow total ER Ca2þ depletion. Subsequently, we
administered 500 nM Iono, a Ca2þ ionophore. After the Iono-evoked
response, 20 mM of the sodium ionophore (Naþ/Hþ exchanger),
monensin A, was added to release Ca2þ from acidic compartments,
such as lysosomes. A representative Ca2þ trace after sequential
additionof theexaminedagents is shown in Fig. 3B.Quantiﬁcationof
Ca2þ mobilization (i.e., Ca2þ rise), after the administration of each
drug, revealed no statistically signiﬁcant differences between AS-
treated and control cells (Fig. 3C). Similar results were obtained in
Ca2þ-containing conditions (data not shown).
Additionally, to further support our data regarding AS-induced
Ca2þ entry, we investigated Cch-induced Ca2þ mobilization ki-
netics in differentiated cells exposed to secreted CM, WT and CM,
WTþ. Interestingly, the rate of Ca2þ buffering after stimulationwith
Cch in Ca2þ-containing compared with Ca2þ-deprived conditions
was signiﬁcantly slower in AS-treated compared with control cells
(Fig. 3D). Because Cch triggers Ca2þ inﬂux from the extracellular
space as a secondary effect, the observed latency further supports
that CM, WT potentiates Ca2þ entry from the plasma membrane,
not only after stimuli such as Tg, but also on more physiological
stimulations such as Cch.mobilization was observed. (C) Representative Ca2þ recordings from cells treated with CM,
Ca2þ-containing conditions (black curve). Quantitative analysis of the time lapse (DT1/2) in th
cells treated with CM, WT in Ca2þ-containing conditions, compared with the control-treat
Ca2þ-deprived conditions (left panel). Graph depicting Ca2þ mobilization (DnM) after the
mobilization after FCCP/Oligo addition in the cells treated with CM, WT was observed (n
free cytosolic Ca2þ; Cch, carbachole; CM, conditioned medium; CM, WTþ, control CM;
p-triﬂuromethoxy-phenylhydrazone; Iono, ionomycin; Mon, monensin A; Oligo, oligomycinAltogether, these results show a facilitated calcium entry in cells
cultured with CM, WT, with no apparent preferential Ca2þ dis-
tribution in a subcellular compartment. However, it is important to
note that therewas a higher Iono-evoked Ca2þ release in AS-treated
compared with control cells, in Ca2þ-deprived conditions (Fig. 3B,
right panel). Although it did not reach statistical signiﬁcance, this
trend implies the participation of a different subcellular Ca2þ pool.
Therefore, we examined whether the mitochondria could be a po-
tential pool for Ca2þ sequestration. To this end, 5 mM of the mito-
chondrial uncoupler, FCCP, together with 2.5 mg/mL Oligo were
added to control and AS-treated cells. Oligo prevents ATP con-
sumption via the reversed mode activity of the F1/F0 synthase. In
Ca2þ-deprived conditions, addition of FCCP with Oligo discharges
mitochondrial Ca2þ stores, causing a rise of cytosolic [Ca2þ]i, which
reﬂects the mitochondrial Ca2þ load (Hettiarachchi et al., 2009).
Secreted AS-treated cells exhibited a more profound response to
the FCCP/Oligo treatment (Fig. 3E). Quantiﬁcation of the Ca2þ
mobilization on drug administration (expressed as DnM [Ca2þ]i at 4
minutes after drug addition) revealed signiﬁcantly higher levels of
mitochondrial Ca2þ content in AS-treated cells compared with
control cells (32.83 2.97 and 86.36 9.75, comparing cells treated
with CM, WTþ and CM, WT, respectively) (Fig. 3E). These results
suggest that on exposure of recipient cells to CM, WT, part of the
excessive Ca2þ entry is driven to the mitochondrial Ca2þ pool.
3.4. Cell-secreted AS leads to a profound increase in CCE in primary
rat cortical neurons
We have previously shown that primary cortical neurons are
also susceptible to secreted AS neurotoxic effects (Emmanouilidou
et al., 2010). We further examined whether application of cell-
secreted AS on primary rat cortical neurons had similar effects on
Ca2þ inﬂux. To this end, 7-day-old rat cortical neurons were treated
with CM, WT or CM, WTþ for 8 hours, after loading with Fura 2-
AM and changes in CCE were recorded. As shown in Fig. 4, cortical
neurons receiving secreted AS exhibited a profound increase inWTþ and CM, WT illustrating the response to Cch in Ca2þ-deprived (red curve) and
e Cch curve revealed a signiﬁcant delay in the decay of Cch-evoked Ca2þ release in the
ed cells (n ¼ 3; * p < 0.05). (D) Representative Ca2þ traces on addition of FCCP/Oligo in
discharge of mitochondrial Ca2þ stores (right panel). A signiﬁcant increase of Ca2þ
¼ 3, in duplicate; ** p < 0.01). Abbreviations: AS, a-synuclein; Ca2þ, calcium; [Ca2þ]i,
CM, WT, AS-containing medium; F/F, ﬂuorescence ratio; FCCP, carbonyl cyanide
; Tg, thapsigargin.
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ratio 143.3  3.79 or 238.7  17.5 in cells treated with CM, WTþ
and CM, WT, respectively), conﬁrming the results obtained with
differentiated SH-SY5Y cells.3.5. Reduction of cytosolic Ca2þ levels protects from secreted AS-
induced neurotoxicity
To investigate whether extracellular AS mediates its pathogenic
actions through increased Ca2þ inﬂux, we used chemical com-
pounds that chelate intracellular or extracellular Ca2þ or prohibit
Ca2þ from entering the cell. Six-day differentiated SH-SY5Y cells
(Fig. 5A) and 7-day-old rat cortical neurons (Fig. 5D) were incubated
for 24 hours at 37 C with CM,WT or CM,WTþ, in the presence or
absence of nif or cntx, and the intracellular or extracellular Ca2þ
chelators, BAPTA-AM (BAPTA) or EGTA, respectively. In both cell
types, the presence of extracellular AS led to a decrease in neuronal
survival, which was mitigated on addition of either nif, cntx, BAPTA,Fig. 5. Reduction of cytosolic Ca2þ levels protects neuronal cells against secreted AS-mediat
WT or CM, WTþ for 24 hours (A, and C) or 16 hours (B), in the absence or presence of Ca2þ
all conditions. All compounds signiﬁcantly increased viability (n ¼ 3, in triplicate; *** p < 0.00
CM, WT in the presence or absence of Ca2þmodulators, # p< 0.05 comparing AS-treated ce
were treated with CM, WT or CM, WTþ, in the presence or absence of Ca2þ modulators for
had a protective effect on cultures treated with CM, WT (n ¼ 4, in triplicate; * p < 0.05, fo
treated with CM, WT in the absence/presence of Ca2þ modulators). All data are corrected
Ca2þ, calcium; CM, conditioned medium; CM, WTþ, control CM; CM, WT, AS-containing mor EGTA (Fig. 5A and D). Drug application had no background
toxicity, conﬁrmed in control experiments.
To decipher whether AS-induced Ca2þ deregulation is directly
linked to the observed cell death, Ca2þ modulators were added for
the ﬁrst 8 hours together with CM, WT. Subsequently, the com-
pounds were removed and CM, WT was added to the cells for
additional 8 or 16 hours. We found that the 8-hour treatment with
the chelating compounds and the VOC inhibitors was sufﬁcient to
protect differentiated cells from AS-mediated toxicity at all time
points (Fig. 5B and C). These results indicate that disturbances in
Ca2þ homeostasis are the primary event in AS-triggered neurotoxic
cascade.3.6. Calpain activation is implicated in the extracellular AS-evoked
neurotoxic effects
We have previously shown that treatment of neuronal cells with
secreted AS results in caspase-3 cleavage (Emmanouilidou et al.,ed neurotoxicity. (AeC) Differentiated SH-SY5Y cells were incubated with secreted CM,
modulators. Neuronal survival was estimated by counting the number of intact nuclei in
1 for cells treated with CM, WTþ versus CM, WT; ### p < 0.001 for cells treated with
lls in the presence or absence of BAPTA). (D) Seven-day-old rat primary cortical neurons
24 hours and neuronal survival was measured using the same method. All compounds
r cells treated with CM, WTþ vs. CM, WT, using unpaired t test; ## p < 0.01, for cells
to the baseline of control cells treated with CM, WTþ. Abbreviations: AS, a-synuclein;
edium.
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(Camins et al., 2006) and to be activated in the setting of excess Ca2þ,
we aimed to examine whether calpains are involved in the secreted
AS-induced neurotoxicity. We incubated differentiated SH-SY5Y cells
with CM, WT, CM, WTþ, or unconditioned medium (vehicle) for 8,
16, and 24 hours. Calpain activity was determined in the homogenates
of the recipient cells using a calpain-speciﬁc ﬂuorogenic substrate. As
depicted in Fig. 6A, a statistically signiﬁcant increase in calpain activity
was observed after 24-hour incubation with AS (393.7  45.03, 499.8
 17.31, and 679.7 30.47, for the cells treatedwith vehicle, CM,WTþ,
and CM, WT, respectively). The speciﬁcity of the reaction was veri-
ﬁed by the addition of the speciﬁc CI, which, as expected, resulted in a
signiﬁcant decrease of calpain activity (Fig. 6A, right panel).
We reasoned that if calpains are indeed activated during the
process of AS-induced toxicity, their inactivation should result in
an increase of cell survival after AS treatment. To test this hypoth-
esis, we incubated cells with CM,WT in the presence or absence of
the CI, for 24 hours. Addition of 1 mM CI greatly improved cell
morphology (data not shown) and signiﬁcantly increased cell
viability (Fig. 6B). In a similar fashion to the survival assays with the
Ca2þ modulators, we investigated whether calpain activation is a
primary event for the observed death. CI was added for 8 hours
together with the CM, WT. Then, the inhibitor was removed and
the cells were incubated for an additional 8 hours or 16 hours with
CM, WT alone. Such treatment showed a trend of protection, after
16-hour incubation with CM, WT (82.38  3.57 and 94.75  4.39,Fig. 6. Activation of calpains in recipient cells is a late effect of secreted AS. (A) Differentiat
(vehicle) for 8, 16, and 24 hours. (Left panel) Increased calpain activation was detected in AS
## p < 0.01, comparing cells treated with CM, WTþ and CM, WT). (Right panel) Speciﬁcity
WT). (BeD) Quantitative analysis of the percentage of cell survival after treatment with C
points). Statistics were performed using 1-way analysis of variance followed by Tukey’s post
C, and D; # p < 0.05 and ### p < 0.001, for cells treated with CM, WT in the presence or ab
or CM, WTþ in the presence or absence of 5.0 mM CI for 24 hours. Abbreviations: AS, a-synuc
WT, AS-containing medium.for the cells treated CM, WT, in the absence or presence of CI,
respectively) (Fig. 6C), but reached statistical signiﬁcance only after
24 hours of incubation (74.25  4.40 and 118.8  3.58, for the cells
treated CM, WT, in the absence or presence of CI, respectively)
(Fig. 6D).
Similar experiments were performed in rat cortical cultures
treated with CM, WT in the presence or absence of the CI for 24
hours. Such treatment showed that calpain inhibition also
improved the survival of primary neurons exposed to AS, however,
this effect did not reach statistical signiﬁcance (Fig. 6E).
3.7. Interaction of secreted AS with the plasma membrane of
recipient cells
In our previous work, we showed that secreted AS could
exert its deleterious effects without frank internalization by
differentiated SH-SY5Y cells (Emmanouilidou et al., 2010). Hence
we wanted to investigate a potential association between AS and
the plasma membrane of recipient cells. To do so, we examined
changes in the microﬂuidic properties of the membrane of
AS-treated cells. Cells were treated with CM from induced AS-
overexpressing cells, or uninduced cells for 8 hours and incu-
bated with 1-pyrenedodecanoic acid (2 mM). 1-Pyrenedodecanoic
acid excimers break into monomers in the lipophilic interior of the
membrane giving a distinct ﬂuorescence spectrum that is indica-
tive of the microﬂuidic properties of the membrane (Dafnis et al.,ed SH-SY5Y cells were incubated with CM, WT, CM, WTþ, or unconditioned medium
-treated cells (n ¼ 3; *** p < 0.001, comparing cells treated with vehicle and CM, WT;
of the assay was veriﬁed using CI (n ¼ 4; * p < 0.05, comparing cells treated with CM,
M, WTþ or CM, WT in the presence or absence of CI (n ¼ 4 in triplicate for all time
hoc test (** p < 0.01 and *** p < 0.001, for cells treated with CM, WTþ vs. CM, WT in B,
sence of CI in B, and D). (E) Primary rat cortical neurons were incubated with CM, WT
lein; CI, calpain inhibitor I A6185; CM, conditioned medium; CM, WTþ, control CM; CM,
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ﬂuidity with membrane rigidity bringing monomers in close
proximity so as to create excised dimers, termed excimers. As
shown in Fig. 7A, the excimer to monomer ratio is signiﬁcantly
reduced in AS-treated cells (1.488  0.071 for CM, WT, mean 
SEM; n ¼ 6) compared with CM, WTþ-treated cells (1.725  0.024
for CM, WTþ, mean  SEM; n ¼ 6), implying increased membrane
ﬂuidity. To exclude the possibility of dox interference in this setup,
we collected CM from the Tet-Off parental SH-SY5Y line (2.22)
expressing only the transactivator factor, in the absence or pres-
ence of dox. In both cases the excimer to monomer ratio was
similar to that of the cells treated with the CM, WTþ, suggesting
that dox does not interfere with the ﬂuidity assay. The ether
phospholipid, miltefosine, known to directly interact and incor-
porate into the cell membrane, was used as a positive control for
increased membrane ﬂuidity (Fig. 7B).3.8. The observed increase in Ca2þ entry is mostly attributed to the
free extracellular- rather than the exosome-associated AS
Because AS is partly secreted via exosomes (Emmanouilidou
et al., 2010), we ﬁnally sought to investigate the contribution of
exosomes in the observed Ca2þ entry. We fractionated CM, WT
and CM, WTþ into exosome-depleted supernatant (S100 and
S100þ, respectively) and into exosome-enriched pellet (P100 and
P100þ, respectively). Full CM and S100 supernatants were
concentrated with using 3-kDa cutoff ﬁlters. P100 fractions were
solubilized in RIPA buffer. Western blot analysis (Fig. 8A) revealed
that only a small portion of secreted AS is present in the exosomal
fraction, in accordance with our previous results (Emmanouilidou
et al., 2010). Alix and ﬂotillin-1 were used as biochemical markers
for the exosome-enriched fraction, and BSA was used as loading
control for CM and S100.Fig. 7. Application of secreted AS-containing medium to neuronal cells affects their plasm
control (CM, 2.22þ, CM, 2.22, CM, WTþ) for 8 hours. Secreted AS induced changes in t
depicts the excimer (468 nm) to monomer (395 nm) ratio (n ¼ 6; *** p < 0.001 comparing th
Increased plasma membrane ﬂuidity on treatment of differentiated SH-SY5Y cells with He
using unpaired t test). Abbreviations: AS, a-synuclein; CM, conditioned medium; CM, WTExosomes from the CM, WT medium (P100) were added in
the S100þ supernatant from the CM, WTþ (S100þ/P100) and vice
versa to yield an S100/P100þ preparation. Cells were incubated
with CM, WT, control medium, or 1 of the previously described
preparations (S100þ, S100, S100þ/P100, and S100/P100þ) for 8
hours. The recipient cells were loaded with Fura 2-AM, and ER
depletion-induced Ca2þ inﬂux was measured, as described earlier in
text (Fig. 8B). Quantiﬁcation of Ca2þ inﬂux revealed that the observed
increase is attributed largely to free extracellular AS (S100) (per-
centage of Ca2þ inﬂux,117.2 8.79 and 111.9 10.87, for cells treated
with CM, WT and S100, respectively). The addition of the
exosome-associated AS (P100) in the control S100þ supernatant
did not signiﬁcantly alter the CCE. This suggests that mainly free
extracellular AS accounts for secreted AS-facilitated Ca2þ entry. This
might be attributed to AS concentration, because only a small portion
of secreted AS is packed in exosomes (Fig. 8A). Finally, the addition of
P100þ to the S100 did not lead to dramatic alterations of the CCE
(percentage of Ca2þ inﬂux 111.9  10.87 and 101.3  7.68, for cells
treated with S100 and S100/P100þ, respectively), suggesting that
the exosomes per se do not inﬂuence CCE.4. Discussion
We have previously shown that cell-produced secreted AS is
toxic to neuronal cells. Importantly, this toxicity did not appear to
involve internalization of AS by the recipient neurons
(Emmanouilidou et al., 2010). The aim of the current study was to
investigate whether the effects of secreted AS on the recipient cells
involve alterations at the level of the plasma membrane and
deregulation of Ca2þ homeostasis.
To capture early events that could be pathologically relevant, the
8-hour treatment with CM containing secreted AS was chosen,
because until that time point there are no overt signs of cellular
degeneration. According to our results, 8-hour incubation witha membrane ﬂuidity. (A) Differentiated SH-SY5Y cells were treated with CM, WT or
he microﬂuidic properties of the plasma membrane of the recipient cells. The graph
e cells treated with CM, WT and control CMs [CM, 2.22þ, CM, 2.22, CM, WTþ]). (B)
PC for 8 hours (n ¼ 5; ** p < 0.01, comparing the cells treated with vehicle and HePC,
þ, control CM; CM, WT, AS-containing medium; HePC, miltefosine.
Fig. 8. Secreted AS-induced increase of CCE in recipient differentiated SH-SY5Y cells is mainly attributed to free AS. Control or secreted AS-containing CM was fractionated to yield
exosome-depleted CM (S100þ, S100, respectively) and exosome-enriched pellet (P100). (A) CM, WTþ/, S100þ/, and P100þ/ were analyzed using Western immunoblot with
antibodies against AS, ﬂottilin-1, alix, and BSA. (B) The P100 isolated from CM, WT (P100) was mixed with S100þ (S100þ/P100) and vice versa to create the S100/P100þ
preparation. Differentiated SH-SY5Y cells were treated either with CM, WTþ or CM, WT or with one of the following preparations: S100þ, S100, S100þ/P100, S100/P100þ, for
8 hours and CCE was measured. The graph illustrates quantiﬁcation of CCE normalized to Tg-evoked Ca2þ release (n ¼ 3, in duplicate; * p < 0.05 comparing cells treated with CM,
WTþ and cells treated with CM, WT ; # p < 0.05, comparing between cells treated with S100þ and cells receiving S100, using unpaired t test). Abbreviations: AS, a-synuclein;
BSA, bovine serum albumin; Ca2þ, calcium; CCE, capacitative calcium entry; CM, conditioned medium; CM, WTþ, control CM; CM, WT, AS-containing medium; dox, doxycycline;
Tg, thapsigargin.
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a signiﬁcant increase in depleted ER-evoked Ca2þ entry (CCE), in
differentiated SH-SY5Y cells and primary rat cortical neurons. The
observed phenomenon greatly relies on the presence of secreted
AS, because immunodepletion of the protein from the CM before
administration to the cells does not alter CCE. Importantly, the
presence of extracellular AS did not have any effect on the CCE of
proliferating cells, which we have shown to be less susceptible to
AS-conferred toxicity (Emmanouilidou et al., 2010). Additionally,
reduction of cytosolic or extracellular Ca2þ levels via the BAPTA and
EGTA Ca2þ chelators, respectively, spared recipient neuronal cells
from AS-evoked toxicity. These data indicate that deregulation of
Ca2þ homeostasis of the recipient cells is responsible, at least in
part, for the neurotoxic potential of secreted AS. This raises the
possibility that the differential toxic effects of secreted AS in neu-
ronally differentiated versus proliferating cells (Emmanouilidou
et al., 2010) might be related to its ability to alter Ca2þ homeosta-
sis in the former, but not in the latter. Although an interplay be-
tween extracellular AS and alterations of Ca2þ homeostasis in the
recipient cells has been suggested in previous reports, these were
largely based on the use of recombinant AS; the current study is, to
our knowledge, the ﬁrst that etiologically links such early Ca2þ
perturbations to secreted AS-mediated neurotoxicity.
To further elucidate the neurotoxic pathway triggered by
secreted AS, we investigated the participation of plasmamembrane
Ca2þ channels. Because CCE was found to be increased in the
presence of secreted AS, we sought to examine the involvement of
SOCs. Although inhibition of SOCs by the speciﬁc inhibitor SKF,
resulted in a signiﬁcant reduction of CCE in control and AS-treated
differentiated cells, the difference between the 2 groups in the
presence of the inhibitor was not completely abolished. Such a
ﬁnding implies that other plasma membrane channels could
contribute to the AS-facilitated Ca2þ entry. Therefore we examined
the role of the L- and N-type VOCs, using pharmacological inhibi-
tion with nif and cntx, respectively. Such treatment signiﬁcantly
reduces CCE to the control levels in differentiated cells, greatly
alleviating AS-induced Ca2þ entry, suggestive of the involvement of
VOCs in the observed phenomenon. In accordance with these
ﬁndings, direct stimulation of VOCs by KCl depolarization led to a
signiﬁcantly higher Ca2þ inﬂux in AS-treated cells compared with
the control cells. Notably, inhibition of either L- or N-type VOCs
greatly reduced Ca2þ inﬂux on depolarization in both groups,abolishing the difference between them. These ﬁndings prove the
proper function of VOCs in the described cellular system and more
importantly, verify the role of VOCs in secreted AS-evoked Ca2þ
deregulation. Considering that we did not ﬁnd any changes in the
protein levels of VOCs (data not shown) on exposure of the cells to
secreted AS, the described Ca2þ increase cannot be attributed to an
upregulation of the expression levels of these channels. Instead, we
saw that the presence of extracellular AS increased membrane
ﬂuidity of the recipient neuronal cells, potentially allowing the
redistribution and clustering of plasma membrane receptors
(including Ca2þ-dependent channels), which in turn might facili-
tate their activation and sensitivity to Ca2þ. Nonetheless, we cannot
exclude the possibility of a direct interaction between secreted AS
and the plasma membrane receptors, resulting in alteration of their
function.
Because recombinant AS species have been shown to interact
with artiﬁcial and biological membranes creating annular pores
(Danzer et al., 2007; Tsigelny et al., 2012), we investigated the effect
of AS on an Iono-evoked response. If the interaction of AS with the
plasma membrane caused the formation of pores, the Iono-evoked
response would result in a profound Ca2þ rise, in Ca2þ-containing
conditions. Nevertheless, we found no signiﬁcant difference in
[Ca2þ]i between AS-treated and control cells suggesting that
the likelihood of pore formation (at least at this early time point)
is unlikely. However, we cannot exclude the possibility that
such pores are formed at later time points (Schmidt et al., 2012;
Tsigelny et al., 2012). The notion that secreted AS perturbs the
normal function of the plasma membrane of the recipient cells, by
facilitating increased Ca2þ inﬂux, is further supported by the
signiﬁcantly slow buffering rate of the Cch-evoked Ca2þ rise in
Ca2þ-containing compared with Ca2þ-deprived conditions, exhibi-
ted by AS-treated cells compared with the control cells.
Despite the profound increase in the observed Ca2þ entry, no
signiﬁcant changes in the steady-state levels of [Ca2þ]i were
measured in AS-treated cells compared with control cells.
Sequential Ca2þ release from the ER and the acidic stores did not
reveal any striking differences in both Ca2þ-depleted and Ca2þ-
containing conditions, excluding the possibility of alterations in
Ca2þ mobilization. Direct discharge of the mitochondrial Ca2þ
content using simultaneous administration of the mitochondrial
uncoupler FCCP and Oligo, showed signiﬁcantly increased Ca2þ
sequestration in AS-treated cells, suggestive of mitochondrial Ca2þ
K. Melachroinou et al. / Neurobiology of Aging xxx (2013) 1e1312overload. It is possible that such overload might lead to mito-
chondrial dysfunction, thus linking extracellular AS and Ca2þ
overload to the mitochondrial theory of PD pathogenesis (Benner
et al., 2004; Cali et al., 2012; Vekrellis and Stefanis, 2012; Zhou
et al., 2004).
Uncontrolled Ca2þ entry can result in the activation of calpains, a
speciﬁc type of cystein- protease that responds to Ca2þ signals
(Medeiros et al., 2012). An increasing body of evidence gradually
cements the notion that abnormal activation of calpains is 1 of the
major culprits in a wide spectrum of brain disorders (Camins et al.,
2006). However, the precisemechanismviawhich calpains regulate
cell death pathways remains to be deciphered. Calpain activity was
found to be increased in the protein preparations extracted from
cells treated with AS for 24 hours, suggesting that calpain activation
is a secondary event that follows Ca2þ deregulation. Considering
that calpains can mediate caspase cleavage and activation (Camins
et al., 2006), and that secreted AS-induced toxicity results in
caspase-3 cleavage (Emmanouilidou et al., 2010), these data suggest
a potential cross-talk between calpains and caspases. In our study,
pharmacological inhibition of calpains protected neuronal cells
from AS-induced death, further reinforcing the involvement of
calpains in the described neurodegenerative process. However, this
effect was more profound in differentiated SH-SY5Y cells than in rat
cortical neurons, possibly because higher doses and more effective
calpain inhibition were not achieved in the latter case, because of
pharmacological toxicity observed with higher doses. In any case,
the incomplete effects of calpain inhibition in rat cortical neurons
suggest that other death pathways could contribute to the observed
neurotoxicity.
It is important to note that an 8-hour treatment with chelating
compounds (BAPTA, EGTA) and VOC inhibitors was enough to
protect differentiated SH-SY5Y cells from 16 or 24 hours of total
incubation with CM, WT, thus placing Ca2þ deregulation at the
beginning of the AS-triggered neurotoxic cascade. On the contrary,
similar administration of CI started to be protective after the 16-
hour incubation with CM, WT and showed maximum protection
after the 24-hour treatment. Taking into account the enzymatic
activity data, which shows calpain activation after 16 hours of
exposure to secreted AS, the above ﬁnding implies that calpains
might be activated at 16 hours (albeit at low, nondetectable levels),
but this activation was signiﬁcant only at 24 hours. Therefore, it
seems that calpain activation is 1 of the late events of the secreted
AS-evoked neurotoxic cascade, downstream Ca2þ deregulation.
However, further investigation is required to elucidate the precise
involvement of calpains in this phenomenon.
We have shown that AS species can be delivered to the extra-
cellular space, at least partly, via their association with exosomes.
Measurements of CCE in recipient cells treated with free extracel-
lular AS or exosome-associated AS preparations, revealed that free
extracellular AS was more potent in inducing increased Ca2þ entry,
compared with the exosome-associated protein. This difference in
Ca2þ responsemight be because of the conformational changes that
AS undergoes on packaging into exosomes which might affect its
biochemical properties. In addition, considering that only a minor
fraction of secreted AS is associated with exosomes (Danzer et al.,
2012), this result might also reﬂect concentration differences.
Concluding, our ﬁndings indicate that secreted AS has neuro-
toxic effects, at least in part, through engagement of the Ca2þ ho-
meostatic machinery. In this context, handling of Ca2þ signaling
cascades might represent a potential therapeutic target for PD and
related synucleinopathies by alleviating secreted AS-conferred
neurotoxicity. Furthermore, our study provides a number of
important novel mechanistic insights regarding the effect of
secreted AS on neuronal cells. Initial effects leading to increased
Ca2þ inﬂux are linked to altered membrane ﬂuidity, likely causingclustering or oversensitization of VOCs, whereas pore formation
does not appear to play a role at these early time points. In
the further cascade of events, calpain activation and, possibly,
mitochondrial Ca2þ overload, are important factors leading to
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